久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

Moscow claims lead in vaccine hunt

By REN QI in Moscow | China Daily | Updated: 2020-07-15 10:13
Share
Share - WeChat
A scientist dilutes samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory in Saint Petersburg, Russia June 11, 2020. [Photo/Agencies]

Russian medical researchers have claimed the lead in the race to develop a vaccine for COVID-19.

Media reports say that two vaccine candidates have completed the second phase of trials-the last of which were on humans-and will be made available, initially, to a limited number of people who step forward for injections next month.

While the reports refer to the vaccines as having completed all trials, a leading researcher behind the project said their limited public distribution-slated for Aug 14-15-is the equivalent of a phase III trial.

Three entities, including two Chinese companies, have entered phase III trials-or the final stage of human testing-for their vaccines, Reuters earlier reported.

In Russia, the two vaccines have been developed by the Gamaleya National Research Center for Epidemiology and Microbiology in Moscow. The Moscow center was given the go-ahead from authorities for the latest round of clinical trials that began on June 18.

With the trials completed, Alexander Gintsburg, the director of the Gamaleya research center, said a small amount of the vaccines will be made available to ordinary Russians over Aug 14-15-likening this development, with the follow-up monitoring, to a phase III trial.

The first vaccine, in the form of a solution for intramuscular administration, was put through trials at the Burdenko Military Hospital.

At the same time, the second candidate vaccine-in the form of a powder prepared as a solution for intramuscular administration, was given to 18 volunteers at Sechenov First Moscow State Medical University.

Gintsburg said the administration of doses to those who come forward next month would proceed under strict supervision.

Early results from the first small-scale human trial of the vaccines developed by the Gamaleya research center had shown them to be safe, according to a report by the RIA news agency on Sunday.

A medical worker conducts daily rounds with a participant in a coronavirus vaccine trial during tests at a hospital in Moscow. CHINA DAILY

Treatment might be free

It's envisaged that the vaccines will be provided to the public in designated medical institutions and, possibly for free, with the expense borne by the government.

Private companies would begin mass production of the vaccines by September, Gintsburg said of the envisaged timeline.

In the human trials at the Sechenov First Moscow State Medical University that began last month, nine of the 18 volunteers received one dose of vaccine, and the other half were given the prospective booster dose to test.

"The research has been completed and it proved that the vaccine is safe," said Yelena Smolyarchuk, the head of Sechenov University's clinical research center.

Each group of the volunteers will be discharged from the Sechenov University facility, on Wednesday and next Monday, after spending 28 days in isolation to guard against exposure to other infections. The volunteers, aged 18 to 65, will be monitored for a further six months after their release.

"Data currently available... shows the volunteers have developed an immune response to the coronavirus vaccine," the Russian Defense Ministry, which is involved in the trials, said on Monday. It added that a further 20 volunteers were administered one of the vaccines at a military hospital on June 23.

The decision to involve the general public in vaccine trials underscores Russia's desire to move ahead fast with its testing of the sought-after coronavirus vaccine, said the Moscow Times.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 爱久久精品国产 | 婷婷色综合久久五月亚洲 | 久久久9999久久精品小说 | 精品三级网站 | 国产女厕偷窥系列在线视频 | 看成年女人免费午夜视频 | 美女毛片儿 | 亚洲国产精品网 | 暴操女人 | 99视频网 | 国产精品区在线12p 国产精品人成 | 久久国产精品久久久久久久久久 | 男女男精品视频免费观看 | aaaa欧美高清免费 | 国产一级视频久久 | 久操免费 | 毛片手机在线观看 | 国产大片线上免费观看 | 99re5久久在热线播放 | 九九热爱视频精品视频高清 | 日产国产精品亚洲系列 | 亚洲男女网站 | 一区二区三区中文国产亚洲 | 亚洲一区视频在线 | 亚洲精品xxx | 尤蜜网站在线进入免费 | 日韩精品在线播放 | 91精品一区二区三区在线观看 | 深夜做爰性大片很黄很色视频 | 久久一区二区三区免费播放 | 国产在视频线精品视频www666 | 一级a美女毛片 | 成年人免费在线观看网站 | 在线观看黄网 | 欧美性生交大片免费看 | 免费一级毛片在线播放放视频 | 日本一级看片免费播放 | 一区二区三区免费在线视频 | 欧美黄视频在线观看 | 色九九| 毛片网站观看 |